Sonus Pharma (SNUS) ? Opinions Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sonus Pharma (SNUS) ? Opinions

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: John McCarthy	12/2/2005 4:28:23 PM
	Read Replies (1) of 384

Sonus Pharmaceuticals, Inc. (SNUS) To Present TOCOSOL(R) Paclitaxel Clinical Data In Metastatic Breast Cancer At San Antonio Breast Cancer Symposium Friday, December 2, 2005 SEATTLE--(BUSINESS WIRE)--Dec. 2, 2005--Sonus Pharmaceuticals, Inc. (NASDAQ:SNUS) today announced the scheduled presentation of a poster on TOCOSOL(R) Paclitaxel at the upcoming San Antonio Breast Cancer Symposium, to be held in San Antonio, Texas from December 8-11. The poster presentation will include efficacy data from an ongoing Phase 2 trial in metastatic breast cancer as well as an update on the safety and tolerability of TOCOSOL Paclitaxel for all patients treated to date in the Phase 2 program. hirehealth.com Provided by: BioSpace.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next